Skip to main content

Russian court grants 11.9-billion-ruble claim against former executives of state nanotechnology corporation Rosnano, including Anatoly Chubais

Source: Interfax

A Russian court has granted Rosnano’s 11.9-billion-ruble claim against former executives of the state nanotechnology corporation, including Anatoly Chubais, the news agency Interfax reported, citing the court’s press service.

The lawsuit, filed in December 2025, sought to recover losses tied to the Crocus project. It alleged that investments directed into the project were used to create and finance project companies on terms “unfavorable to Rosnano” and contrary to “the objectives of Rosnano’s activities.”

Crocus was supposed to build a plant to manufacture magnetoresistive RAM, or MRAM. Rosnano and a number of funds invested about $55 million into the charter capital of the company created for this purpose.

Total investment in the MRAM production project exceeded 200 million euros, including 100 million euros co-financed by Rosnano.

Former Rosnano head Chubais published a statement in May 2026 in which he described the criminal prosecution of Rosnano’s executives as “repression” and “a mockery of the law.” The corporation has already filed several lawsuits against Chubais and his former colleagues.

Chubais led Rosnano from 2008, resigned in December 2020, and left Russia in March 2022. Russian President Vladimir Putin said after Chubais’s departure that “a massive financial hole” had been discovered in “the nanotechnology structure he had headed for many years.”

At Meduza, we are committed to transparency about our use of artificial intelligence in the newsroom. The story you’re reading was written by one of our living, breathing journalists and translated from Russian using an AI model configured to follow our strict editorial standards. This translation process is the result of extensive testing and refinements to ensure our English-language coverage is timely and accurate. A Meduza editor reviews every draft before publication.

If you find any errors in this translation, please contact us at [email protected].

To read Meduza’s exclusive content in English, please subscribe to our newsletter.